Tema ETFs
CRL icon

Tema ETFs’s Charles River Laboratories CRL Stock Holding History

Tema ETFs’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$299K Buy
1,012
+315
+45% +$83K 0.01% 491
2026
Q2 		$158K Hold
697
– – 0.01% 540
2026
Q1 		$120K Buy
697
+567
+436% +$105K 0.01% 518
2025
Q4 		$25.9K Buy
+130
New +$23.6K ﹤0.01% 554

Other funds holding CRL

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Confluence Investment Management
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Sendero Wealth Management
Sendero Wealth Management San Antonio, Texas $1B AUM 21.35% 1-Year Est. Return
PensionDanmark
PensionDanmark Copenhagen O, Denmark $12.3B AUM 33.99% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
Mitchell & Pahl Private Wealth
Mitchell & Pahl Private Wealth Oklahoma City, Oklahoma $277M AUM 23.93% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Tema ETFs's CRL Position: Q3 2026 in Review

Tema ETFs increased its Charles River Laboratories (CRL) stake by 45% in Q3 2026, buying an estimated $83K and bringing the position to 1,012 shares worth $299K. The position accounts for 0.01% of the portfolio, ranked #491.

Tema ETFs first reported a position in CRL in Q4 2025 and has held it in 4 quarters since. 76 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • Tema ETFs held 1,012 shares of Charles River Laboratories worth $299K as of Q3 2026.
  • Tema ETFs bought 315 Charles River Laboratories shares in Q3 2026, an estimated $83K.
  • Charles River Laboratories made up 0.01% of Tema ETFs's portfolio in Q3 2026, its #491 holding.
  • Tema ETFs first reported a position in Charles River Laboratories in Q4 2025 and has held it in 4 quarters since.
  • 76 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.